How we ensure unbiased AI predictions
Trained by Clinicians, Not Just Data Scientists
Bias in AI can compound existing healthcare disparities and distort benefit-risk evaluations. ArcaScience's 24 ensemble AI models are trained by clinicians—not just engineers—ensuring predictions reflect medical reality, not algorithmic artifacts.
Continuous Validation Across Diverse Populations
Our models undergo continuous revalidation against diverse clinical populations, therapeutic areas, and geographic regions. We don't train on a single data source or demographic subset—we synthesize global evidence to deliver impartial, context-aware insights that hold up under regulatory scrutiny.
Every insight is traceable to its source
No Black Box. Only Auditable Intelligence.
In pharmaceutical decision-making, "black box" AI is unacceptable. ArcaScience's platform ensures complete transparency: every benefit-risk signal, safety alert, or efficacy insight links directly to its originating data source—whether clinical trial records, peer-reviewed literature, or real-world evidence databases.
No Black Box. Only Auditable Intelligence.
Our AS Profiling Base 100b® maintains full citation metadata for over 100 billion data points, enabling regulatory reviewers and clinical teams to validate findings instantly. No guesswork. No approximations. Only auditable, source-backed intelligence.
Work in other way
Replace Legacy CROs with AI-Powered Intelligence
The pharmaceutical industry has relied on manual literature reviews and expensive CRO services for decades—approaches that are slow, incomplete, and costly. ArcaScience delivers comprehensive benefit-risk insights in seconds, not months.
Free Your Teams for Strategic Decisions
By automating data aggregation, signal detection, and report generation, we eliminate data wrangling. The result: faster regulatory filings, stronger evidence packages, and better-informed go/no-go decisions.
How we ensure unbiased AI predictions
Trained by Clinicians, Not Just Data Scientists
Bias in AI can compound existing healthcare disparities and distort benefit-risk evaluations. ArcaScience's 24 ensemble AI models are trained by clinicians—not just engineers—ensuring predictions reflect medical reality, not algorithmic artifacts.
Continuous Validation Across Diverse Populations
Our models undergo continuous revalidation against diverse clinical populations, therapeutic areas, and geographic regions. We don't train on a single data source or demographic subset—we synthesize global evidence to deliver impartial, context-aware insights that hold up under regulatory scrutiny.
Customizable to your specific pathology
Every Therapeutic Area Has Unique Requirements
Oncology demands nuanced tradeoffs between survival gains and toxicity. Rare diseases require extrapolation from limited populations. Dermatology prioritizes quality-of-life alongside efficacy. One-size-fits-all approaches fail.
Configure Endpoints, Comparators, and Weighting
ArcaScience adapts to your therapeutic context. Define endpoint hierarchies, configure comparator strategies, and weight benefit-risk dimensions according to regulatory expectations and HTA frameworks specific to your indication.
- Dermatology
- Immuno-Inflammation
- Oncology
- Rare Diseases
- Vaccines
- Cardiovascular
You have more questions ?
Yes. ArcaScience offers on-site deployment, ensuring sensitive clinical data remains within your infrastructure. Our platform integrates with existing EDC systems and data warehouses while maintaining compliance with internal governance policies and regional regulations (GDPR, HIPAA).